tiprankstipranks
Sutro Biopharma Inc (STRO)
NASDAQ:STRO
US Market
Want to see STRO full AI Analyst Report?

Sutro Biopharma (STRO) Blogger Opinions & Sentiment

740 Followers

Blogger Sentiment

Bullish: 100.00%
Sector Average
Bullish
STRO Blogger sentiment is based on 2 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
50% Zacks
50% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Upstream Bio, Inc. (UPB) Reports Q2 Loss Tops Revenue Estimates
Zacks
BlackRock, Inc. Adds to Sutro Biopharma Inc (STRO) Stake -- Shares Trade 126% Above GF Value
GuruFocus
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any
Blogger Name
Blogger Rank
Blog
Date
Blogger Sentiment​
Article
Follow

FAQ

What do Seeking Alpha bloggers think of STRO?
Currently there's no blogger sentiment for STRO.
What do Motley Fool contributors think of STRO?
Currently there's no blogger sentiment for STRO.
What Is STRO’s Blogger Sentiment?
STRO’s Blogger Sentiment is Bullish.
    What was the most recent blogger prediction for STRO?
    The most recent blogger prediction for STRO was made by Zacks Equity Research, who was Bullish on the stock.
      How can I follow the stock ratings of top Top Financial Bloggers?
      Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Stocks with the Highest Top Blogger Ratings in the Healthcare sector
        CADLCandel Therapeutics
        MLTXMoonLake Immunotherapeutics
        SMMTSummit Therapeutics
        TGTXTG Therapeutics
        PGENPrecigen